Takeda Pharmaceutical Company Limited
HETEROCYCLIC AMIDE COMPOUND

Last updated:

Abstract:

Provided is a heterocyclic amide compound that may have a PRS inhibitory action and is expected to be useful as a prophylactic or therapeutic agent for PRS associated diseases and the like including cancer. A compound represented by the following formula (I): ##STR00001## wherein each symbol is as described in the DESCRIPTION, or a salt thereof.

Status:
Application
Type:

Utility

Filling date:

14 Sep 2017

Issue date:

28 Nov 2019